Methodology to Incorporate Biologically Effective Dose and Equivalent Uniform Dose in Patient-Specific 3-Dimensional Dosimetry for Non-Hodgkin Lymphoma Patients Targeted with 131I-Tositumomab Therapy-Reference-Cited by-同舟云学术

Methodology to Incorporate Biologically Effective Dose and Equivalent Uniform Dose in Patient-Specific 3-Dimensional Dosimetry for Non-Hodgkin Lymphoma Patients Targeted with 131I-Tositumomab Therapy

Published:2010-03-17 Issue:4 Volume:51 Page:654-659
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Amro Hanan,Wilderman Scott J.,Dewaraja Yuni K.,Roberson Peter L.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference26 articles.

1. Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging-Based Internal Dosimetry

2. Update: The Case for Patient-Specific Dosimetry in Radionuclide Therapy

3. Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

4. Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody

5. The Radioisotope Contributes Significantly to the Activity of Radioimmunotherapy

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological effects of radiopharmaceutical therapy;Frontiers in Nuclear Medicine;2024-04-04

2. Influence on voxel-based dosimetry: noise effect on absorbed dose dosimetry at single time-point versus sequential single-photon emission computed tomography;Nuclear Medicine Communications;2023-04-17

3. Small molecules and conjugates as theranostic agents;RSC Chemical Biology;2023

4. Dosimetry in Radiopharmaceutical Therapy;Journal of Nuclear Medicine;2022-10

5. Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer;Diagnostics;2022-07-21